Results 271 to 280 of about 34,085 (286)
Some of the next articles are maybe not open access.

Off-target effects of cytidine base editor and adenine base editor: What can we do?

Journal of Genetics and Genomics, 2019
Abstract Base editors (BEs) is a powerful tool that could edit the genome efficiently without inducing DNA double-strand breaks (DSBs). Recently, off-target DNA and RNA mutations of BEs were found, rasing concerns about its precision and safety. Here we discuss some strategies that might eliminate off-target effects of BEs.
Puping Liang, Jinkun Wen, Junjiu Huang
openaire   +2 more sources

Adenine base editor excels at fixing point mutations

C&EN Global Enterprise, 2017
Many diseases are caused by single-base mutations in genomic DNA. Scientists have long searched for methods to correct such mutations to treat these genetic diseases. Last year, David R. Liu of Harvard University and coworkers developed a technique called base editing that fixes some single-base mutations.
openaire   +1 more source

Genome-wide target specificity of CRISPR RNA-guided adenine base editors

Nature Biotechnology, 2019
Adenine base editors1 enable efficient targeted adenine-to-guanine single nucleotide conversions to induce or correct point mutations in human cells, animals, and plants1-4. Here we present a modified version of Digenome-seq, an in vitro method for identifying CRISPR (clustered regularly interspaced short palindromic repeats)-induced double-strand ...
Daesik Kim   +4 more
openaire   +2 more sources

Correcting a patient-specific Rhodopsin mutation with adenine base editor in a mouse model

Molecular Therapy
Genome editing offers a great promise to treating human genetic diseases. To assess genome-editing-mediated therapeutic effects in vivo, an animal model is indispensable. The genomic disparities between mice and humans often impede the direct clinical application of genome-editing-mediated treatments using conventional mouse models.
Feng Gu
exaly   +3 more sources

Hypercompact adenine base editors based on a Cas12f variant guided by engineered RNA

Nature Chemical Biology, 2022
Do Yon Kim   +10 more
openaire   +1 more source

A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing

Nature Biotechnology, 2020
Julian Grünewald   +2 more
exaly  

Engineered Nme2Cas9 Adenine Base Editors to Treat Rett Syndrome

Rett syndrome (RTT) is a severe X-linked progressive neurodevelopmental disorder that primarily affects females in early childhood. Although the FDA has approved the first drug treatment for RTT, no curative therapy is currently available. Precision genome editing technologies—particularly CRISPR-based adenine base editing (ABE)—offer a promising ...
openaire   +1 more source

Home - About - Disclaimer - Privacy